M 373
Pill imprint M 373 has been identified as Hydroxychloroquine sulfate 200 mg.
Hydroxychloroquine is used in the treatment of rheumatoid arthritis; systemic lupus erythematosus; sjogren's syndrome; malaria prevention; malaria (and more), and belongs to the drug classes antimalarial quinolines, antirheumatics. FDA has not classified the drug for risk during pregnancy.
Hydroxychloroquine 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Hydroxychloroquine sulfate Images
- Imprint:
-
M
373 - Strength:
- 200 mg
- Color:
- White
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
croscarmellose sodium
triacetin
hypromellose
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
povidone
sodium lauryl sulfate
titanium dioxide
- Drug Class:
- Antimalarial quinolines
Antirheumatics - Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0373
More Hydroxychloroquine Sulfate resources
- Hydroxychloroquine (Wolters Kluwer)
- hydroxychloroquine (Cerner Multum)
- hydroxychloroquine (Micromedex) - Includes Dosage Information
- Hydroxychloroquine Sulfate (AHFS DI)
- Hydroxychloroquine Tablets (FDA)
- Hydroxychloroquine Sulfate (Wolters Kluwer)


